Erratum to: Handling Missing Data in Within-Trial Cost-Effectiveness Analysis: A Review with Future Recommendations [0.03%]
缺失数据在成本效用分析中的处理方法：综述及未来研究方向
Andrea Gabrio,Alexina J Mason,Gianluca Baio
Andrea Gabrio
Published Erratum
PharmacoEconomics - open. 2017 Jun;1(2):143. DOI:10.1007/s41669-017-0029-0 2017
Christopher James Sampson,Tim Wrightson
Christopher James Sampson
Handling Missing Data in Within-Trial Cost-Effectiveness Analysis: A Review with Future Recommendations [0.03%]
处理试验内成本效益分析中的缺失数据：回顾与未来建议
Andrea Gabrio,Alexina J Mason,Gianluca Baio
Andrea Gabrio
Cost-effectiveness analyses (CEAs) alongside randomised controlled trials (RCTs) are increasingly designed to collect resource use and preference-based health status data for the purpose of healthcare technology assessment. However, because...
Early Assessment of the Likely Cost Effectiveness of Single-Use Flexible Video Bronchoscopes [0.03%]
一次性柔性支气管镜可能的成本效益的早期评估
Christoffer Lilja Terjesen,Julia Kovaleva,Lars Ehlers
Christoffer Lilja Terjesen
Background: Bronchoscopic procedures are common in the clinical setting, with estimates indicating 500,000 are undertaken per year in the USA alone. These procedures are generally regarded as safe. Unfortunately, a risk o...
Utilization, Spending, and Price Trends for Quinolones in the US Medicaid Programs: 25 Years' Experience 1991-2015 [0.03%]
美国梅迪卡项目中喹诺酮类药物的利用、花费与价格变化：1991-2015年25年的经验总结
Ziyad S Almalki,Xiaomeng Yue,Ying Xia et al.
Ziyad S Almalki et al.
Background: Given that the quinolones is one of the antibacterial classes most frequently used to treat patients with bacterial infections in the United States, any change in prescribing patterns of quinolones will impact...
Cost-Benefit Analysis of Telemedicine Systems/Units in Greek Remote Areas [0.03%]
希腊偏远地区的远程医疗系统/单位的成本效益分析
Marios-Nikolaos Kouskoukis,Charalambos Botsaris
Marios-Nikolaos Kouskoukis
Background: Telemedicine units and information technology systems provide special healthcare services to remote populations using telecommunication technology, in order to reduce or even remove the usual and typical face-...
Issues Related to the Frequency of Exploratory Analyses by Evidence Review Groups in the NICE Single Technology Appraisal Process [0.03%]
证据回顾组在英国NICE单一技术评估过程中探索性分析的频次问题探讨
Eva Kaltenthaler,Christopher Carroll,Daniel Hill-McManus et al.
Eva Kaltenthaler et al.
Background: Evidence Review Groups (ERGs) critically appraise company submissions as part of the National Institute for Health and Care Excellence (NICE) Single Technology Appraisal (STA) process. As part of their critiqu...
Economic Impact of Mirabegron Versus Antimuscarinics for the Treatment of Overactive Bladder in the UK [0.03%]
英国尿失禁患者采用mirabegron治疗相比抗胆碱药物的经济影响研究
Jameel Nazir,Malin Berling,Charles McCrea et al.
Jameel Nazir et al.
Purpose: Our objective was to estimate the economic outcomes of using mirabegron versus antimuscarinics in the treatment of patients with overactive bladder (OAB) from a societal perspective in the UK. ...
Authors' Reply to Holko: "Forecasting Pharmaceutical Prices for Economic Evaluations When There Is No Market: A Review" [0.03%]
作者回复霍尔科关于“当没有市场时，药品经济评估中的药品价格预测回顾”的评论
Ilke Akpinar,Philip Jacobs,Dat T Tran
Ilke Akpinar